{"id":{"repo_id":"marshall","oai_identifier":"oai:mds.marshall.edu:etd-2428"},"canonical_url":"https://search.ndltd.org/etd/marshall/oai:mds.marshall.edu:etd-2428","repository":{"repo_id":"marshall","name":"Marshall University","base_url":"https://mds.marshall.edu/do/oai/"},"display":{"title":"Characterization of cardiovascular function in adult offspring following prenatal exposure to methamphetamine","abstract":"Methamphetamine (meth) is a synthetic stimulant, and its abuse is a significant public health concern in the United States and all over the world. Methamphetamine is a highly addictive drug, and its abuse is widespread among women of child-bearing age. The consequences of methamphetamine abuse are not only of relevance to pregnant women, but also their unborn children, as amphetamine type substances can cross the placental barrier and effect the fetus during gestation. Most previous studies investigating the impact of prenatal methamphetamine exposure on the offspring have focused on neurological and behavioral effects. The goal of this study was to investigate the impact of prenatal methamphetamine exposure on the cardiovascular system of adult offspring. Using a rat model, the primary finding of this work was that prenatal exposure to methamphetamine produces long-lasting and sex-dependent effects in the cardiovascular system of adult offspring. Specifically, prenatal exposure to methamphetamine hypersensitizes the female heart to ischemic injury regardless of whether exposure to methamphetamine occurs during the first or second half of the gestational period. Although this effect of prenatal methamphetamine persists in 2-month-old offspring, it subsides before 1 year of abstinence. This work also demonstrated that prenatal exposure to methamphetamine leads to perivascular adipose tissue dysfunction, disruption of NO signaling, and potentiation of angiotensin II-induced contraction of the aorta in a sex-dependent manner. These data demonstrate that prenatal exposure to methamphetamine produces sex-dependent effects in the heart and vasculature of offspring that persist into adulthood.","abstract_html":"Methamphetamine (meth) is a synthetic stimulant, and its abuse is a significant public health concern in the United States and all over the world. Methamphetamine is a highly addictive drug, and its abuse is widespread among women of child-bearing age. The consequences of methamphetamine abuse are not only of relevance to pregnant women, but also their unborn children, as amphetamine type substances can cross the placental barrier and effect the fetus during gestation. Most previous studies investigating the impact of prenatal methamphetamine exposure on the offspring have focused on neurological and behavioral effects. The goal of this study was to investigate the impact of prenatal methamphetamine exposure on the cardiovascular system of adult offspring. Using a rat model, the primary finding of this work was that prenatal exposure to methamphetamine produces long-lasting and sex-dependent effects in the cardiovascular system of adult offspring. Specifically, prenatal exposure to methamphetamine hypersensitizes the female heart to ischemic injury regardless of whether exposure to methamphetamine occurs during the first or second half of the gestational period. Although this effect of prenatal methamphetamine persists in 2-month-old offspring, it subsides before 1 year of abstinence. This work also demonstrated that prenatal exposure to methamphetamine leads to perivascular adipose tissue dysfunction, disruption of NO signaling, and potentiation of angiotensin II-induced contraction of the aorta in a sex-dependent manner. These data demonstrate that prenatal exposure to methamphetamine produces sex-dependent effects in the heart and vasculature of offspring that persist into adulthood.","abstract_has_math":false,"creators":["Chavva, Hasitha"],"institution":null,"degree_name":"Pharmaceutical Sciences","degree_level":"Dissertation","degree_discipline":"School of Pharmacy","degree_department":null,"school":null,"contributors":["Dr. Boyd R. Rorabaugh, Committee Chairperson","Dr. Daniel A. Brazeau, Committee Member","Dr. Eric R. Blough, Committee Member"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-21T19:57:29Z","subjects":["Maternal and Child Health","Medicine and Health Sciences","Mental and Social Health","Pharmacy and Pharmaceutical Sciences","Public Health","Substance Abuse and Addiction"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://mds.marshall.edu/etd/1423","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://mds.marshall.edu/etd/1423","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://mds.marshall.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Amds.marshall.edu%3Aetd-2428","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Dr. Boyd R. Rorabaugh, Committee Chairperson","Dr. Daniel A. Brazeau, Committee Member","Dr. Eric R. Blough, Committee Member"]},{"key":"dc:creator","label":"Author","values":["Chavva, Hasitha"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2024-05-11T07:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2021-01-01T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["School of Pharmacy"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Pharmaceutical Sciences"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Maternal and Child Health","Medicine and Health Sciences","Mental and Social Health","Pharmacy and Pharmaceutical Sciences","Public Health","Substance Abuse and Addiction"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://mds.marshall.edu/etd/1423"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Methamphetamine (meth) is a synthetic stimulant, and its abuse is a significant public health concern in the United States and all over the world. Methamphetamine is a highly addictive drug, and its abuse is widespread among women of child-bearing age. The consequences of methamphetamine abuse are not only of relevance to pregnant women, but also their unborn children, as amphetamine type substances can cross the placental barrier and effect the fetus during gestation. Most previous studies investigating the impact of prenatal methamphetamine exposure on the offspring have focused on neurological and behavioral effects. The goal of this study was to investigate the impact of prenatal methamphetamine exposure on the cardiovascular system of adult offspring. Using a rat model, the primary finding of this work was that prenatal exposure to methamphetamine produces long-lasting and sex-dependent effects in the cardiovascular system of adult offspring. Specifically, prenatal exposure to methamphetamine hypersensitizes the female heart to ischemic injury regardless of whether exposure to methamphetamine occurs during the first or second half of the gestational period. Although this effect of prenatal methamphetamine persists in 2-month-old offspring, it subsides before 1 year of abstinence. This work also demonstrated that prenatal exposure to methamphetamine leads to perivascular adipose tissue dysfunction, disruption of NO signaling, and potentiation of angiotensin II-induced contraction of the aorta in a sex-dependent manner. These data demonstrate that prenatal exposure to methamphetamine produces sex-dependent effects in the heart and vasculature of offspring that persist into adulthood."]},{"key":"dc:title","label":"Title","values":["Characterization of cardiovascular function in adult offspring following prenatal exposure to methamphetamine"]}]}],"canonical_facts":{"dc:contributor":["Dr. Boyd R. Rorabaugh, Committee Chairperson","Dr. Daniel A. Brazeau, Committee Member","Dr. Eric R. Blough, Committee Member"],"dc:creator":["Chavva, Hasitha"],"dc:date.available":["2024-05-11T07:00:00Z"],"dc:date.created":["2021-01-01T08:00:00Z"],"dc:description.abstract":["Methamphetamine (meth) is a synthetic stimulant, and its abuse is a significant public health concern in the United States and all over the world. Methamphetamine is a highly addictive drug, and its abuse is widespread among women of child-bearing age. The consequences of methamphetamine abuse are not only of relevance to pregnant women, but also their unborn children, as amphetamine type substances can cross the placental barrier and effect the fetus during gestation. Most previous studies investigating the impact of prenatal methamphetamine exposure on the offspring have focused on neurological and behavioral effects. The goal of this study was to investigate the impact of prenatal methamphetamine exposure on the cardiovascular system of adult offspring. Using a rat model, the primary finding of this work was that prenatal exposure to methamphetamine produces long-lasting and sex-dependent effects in the cardiovascular system of adult offspring. Specifically, prenatal exposure to methamphetamine hypersensitizes the female heart to ischemic injury regardless of whether exposure to methamphetamine occurs during the first or second half of the gestational period. Although this effect of prenatal methamphetamine persists in 2-month-old offspring, it subsides before 1 year of abstinence. This work also demonstrated that prenatal exposure to methamphetamine leads to perivascular adipose tissue dysfunction, disruption of NO signaling, and potentiation of angiotensin II-induced contraction of the aorta in a sex-dependent manner. These data demonstrate that prenatal exposure to methamphetamine produces sex-dependent effects in the heart and vasculature of offspring that persist into adulthood."],"dc:identifier":["https://mds.marshall.edu/etd/1423"],"dc:subject":["Maternal and Child Health","Medicine and Health Sciences","Mental and Social Health","Pharmacy and Pharmaceutical Sciences","Public Health","Substance Abuse and Addiction"],"dc:title":["Characterization of cardiovascular function in adult offspring following prenatal exposure to methamphetamine"],"thesis:degree_discipline":["School of Pharmacy"],"thesis:degree_level":["Dissertation"],"thesis:degree_name":["Pharmaceutical Sciences"]},"updated_at":"2026-11-21T19:57:29Z"}